Neuroptis Biotech

Contact
neuroptis.com

Neuroptis Biotech

9 Avenue Maximilien de Robespierre
94400 Vitry-sur-Seine
France
neuroptis.com
Contact
Profile News
Contact

About Neuroptis Biotech

Founded in 2008, Neuroptis Biotech is developing several compounds in dry eye indications, an area that has been rather neglected in favor of pathologies of the retina, these products are ready to enter Phase I clinical trials in 2012. This rapidly-growing market is estimated to be worth over EUR 1.2 billion at the world level.

Read more about Neuroptis Biotech
Facts about Neuroptis Biotech
  • Industry : Pharma

News about Neuroptis Biotech

Neuroptis Biotech

23-Jan-2015 | research and development

Dry eye syndrome: Neuroptis successfully completes the pre-clinical phase for ML7

Neuroptis is looking to establish industrial and financial partnerships to commence human trials

Read news
Neuroptis Biotech

22-May-2012 | research and development

Provence Technologies and Neuroptis Biotech partner to develop a new compound for treating dry eye syndrome

Provence Technologies announced the further strengthening of their collaboration for transferring the chemical development of Neuroptis Biotech’s drug ...

Read news
Show more news about Neuroptis Biotech

Here you will find Neuroptis Biotech